MENU

EXEL Exelixis Forecast, Technical & Fundamental Analysis

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
EXEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EXEL is expected to report earnings to fall 59.52% to 34 cents per share on October 30

Exelixis EXEL Stock Earnings Reports
Q3'24
Est.
$0.34
Q2'24
Beat
by $0.53
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.10
Q3'23
Missed
by $0.05
The last earnings report on August 06 showed earnings per share of 83 cents, beating the estimate of 31 cents. With 1.38M shares outstanding, the current market capitalization sits at 7.41B.
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

EXEL and Stocks

Correlation & Price change

A.I.dvisor tells us that EXEL and CPRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXEL and CPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
-0.77%
CPRX - EXEL
32%
Poorly correlated
-2.52%
RVMD - EXEL
31%
Poorly correlated
-2.51%
HALO - EXEL
30%
Poorly correlated
-4.12%
RIGL - EXEL
29%
Poorly correlated
-2.38%
ALGS - EXEL
27%
Poorly correlated
-5.60%
More

Groups containing EXEL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
-0.77%
drugs
theme (265 stocks)
30%
Poorly correlated
+5.37%
cancer
theme (87 stocks)
28%
Poorly correlated
+0.89%
biotechnology
theme (248 stocks)
28%
Poorly correlated
+5.56%
modules
theme (9 stocks)
28%
Poorly correlated
+1.12%
treatment
theme (61 stocks)
24%
Poorly correlated
+0.91%